fluvoxamine + pindolol

This is a combination of two small molecule drugs, fluvoxamine and pindolol. Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) primarily used to treat obsessive-compulsive disorder and other anxiety disorders. It works by inhibiting the reuptake of serotonin in the central nervous system, thereby increasing serotonin levels and enhancing serotonergic neurotransmission[1][4]. Pindolol is a non-selective beta-adrenergic receptor antagonist (beta-blocker) with intrinsic sympathomimetic activity, used mainly for hypertension and angina pectoris. In psychiatry research, pindolol has been studied as an augmenting agent to SSRIs like fluoxetine or potentially fluvoxamine in treatment-resistant depression or anxiety disorders due to its antagonism at 5-HT1A autoreceptors, which may accelerate or enhance antidepressant response[3]. The combination has been investigated for augmentation strategies in treatment-resistant mood and anxiety disorders but does not have an established unique brand name or widespread clinical use as a fixed-dose product.